Could a common migraine pill help heal spinal cord injuries?
NCT ID NCT06677229
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a migraine drug called Eletriptan (TZ-161) can help people with recent spinal cord injuries. 28 adults with thoracic spinal cord injury will receive either the drug or a placebo for 6 days, alongside standard care. The goal is to check safety and see if it improves recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Eletriptan (a migraine drug, repurposed)
- What this could lead to
- If it works, this could point toward a new treatment to improve recovery after spinal cord injury.
- What could go wrong
- This is a small, early-phase trial (28 people) testing safety and proof-of-concept. The drug may not improve outcomes, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, Spain
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.